Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: Systematic review and meta-analysis

BMJ (Online)

Volumn 363, Issue , 2018, Pages

  Hao, Qiukui ^a,b   Tampi, Malavika ^c   O'Donnell, Martin ^d   Foroutan, Farid ^b   Siemieniuk, Reed A C ^b   Guyatt, Gordon ^b  

^a SICHUAN UNIVERSITY   (China)

^b MCMASTER UNIVERSITY   (Canada)

^c AMERICAN DENTAL ASSOCIATION   (United States)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; PLACEBO; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ALL CAUSE MORTALITY; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CLINICAL DECISION MAKING; CONFIDENCE INTERVAL; DATA BASE; DATA EXTRACTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DUAL ANTIPLATELET THERAPY; HIGH RISK PATIENT; HUMAN; INCIDENCE; INFORMATION PROCESSING; META ANALYSIS; MONOTHERAPY; NEUROPROTECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; STATISTICAL BIAS; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; MORTALITY; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX;

ASPIRIN; BRAIN ISCHEMIA; CLOPIDOGREL; DRUG THERAPY, COMBINATION; HEMORRHAGE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MORTALITY; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SECONDARY PREVENTION; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 85058889910     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.k5108     Document Type: Article

References (38)

1. Amarenco P, Lavallee PC, Monteiro Tavares L, et al, TIAregistry. org Investigators. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med 2018;378:2182-90. doi:10.1056/ NEJMoa1802712
2. Khare S. Risk factors of transient ischemic attack: An overview. J Midlife Health 2016;7:2-7. doi:10.4103/0976-7800. 179166
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. doi:10.1136/bmj.324.7329.71
4. Kernan WN, Ovbiagele B, Black HR, et al, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-236. doi:10.1161/ STR.0000000000000024
5. Sacco RL, Adams R, Albers G, et al, American Heart Association/ American Stroke Association Council on Stroke, Council on Cardiovascular Radiology and Intervention, American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/ American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation 2006;113:e409-49. doi:10.1161/circ.113.10.e409
6. Furie KL, Kasner SE, Adams RJ, et al, American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2011;42:227-76. doi:10.1161/ STR.0b013e3181f7d043.
7. Lansberg MG, O'Donnell MJ, Khatri P. et al. Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e601S-36S.
8. Powers WJ, Rabinstein AA, Ackerson T, et al, American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke 2018;49:e46-110. doi:10.1161/STR.0000000000000158
9. Wang Y, Wang Y, Zhao X, et al, CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11-9. doi:10.1056/NEJMoa1215340
10. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AMFASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurol 2007;6:961-9. doi:10.1016/ S1474-4422(07)70250-8
11. Bhatt DL, Fox KA, Hacke W, et al, CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17. doi:10.1056/NEJMoa060989
12. Benavente OR, Hart RG, McClure LA, Szychowski JM, Coffey CS, Pearce LASPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012;367:817-25. doi:10.1056/NEJMoa1204133
13. Diener HC, Bogousslavsky J, Brass LM, et al, MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331-7. doi:10.1016/S0140-6736(04)16721-4
14. Wang Y, Pan Y, Zhao X, et al, CHANCE Investigators. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. Circulation 2015;132:40-6. doi:10.1161/ CIRCULATIONAHA.114.014791
15. Koziol K, Van der Merwe V, Yakiwchuk E, Kosar L. Dual antiplatelet therapy for secondary stroke prevention: Use of clopidogrel and acetylsalicylic acid after noncardioembolic ischemic stroke. Can Fam Physician 2016;62:640-5.
16. Bowen AMJ, Gavin Y, eds. National clinical guideline for stroke. 5th ed. 2016, www.strokeaudit.org/Guideline/Guideline-Home.aspx2018.07.
17. Bang OY. Considerations When Subtyping Ischemic Stroke in Asian Patients. J Clin Neurol 2016;12:129-36. doi:10.3988/ jcn.2016.12.2.129
18. Kim BJ, Kim JS. Ischemic stroke subtype classification: An asian viewpoint. J Stroke 2014;16:8-17. doi:10.5853/jos.2014.16.1.8
19. Hankey GJ. Dual antiplatelet therapy in acute transient ischemic attack and minor stroke. N Engl J Med 2013;369:82-3. doi:10.1056/ NEJMe1305127
20. Johnston SC, Easton JD, Farrant M, et al, Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 2018;379:215-25. doi:10.1056/NEJMoa1800410
21. Siemieniuk RA, Agoritsas T, Macdonald H, Guyatt GH, Brandt L, Vandvik PO. Introduction to BMJ Rapid Recommendations. BMJ 2016;354:i5191. doi:10.1136/bmj.i5191
22. Wong KS, Wang Y, Leng X. et al. Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: An updated systematic review and meta-analysis. Circulation 2013;128:1656-66. doi:10.1161/ CIRCULATIONAHA.113.003187
23. Gordon H. Guyatt JWB. Risk of Bias in Randomized Trials 2016. http:// growthevidence.com/gordon-h-guyatt-md-msc-and-jason-w-bussedc-phd/ accessed 2018.06.
24. Chang Y, Kennedy SA, Bhandari M. et al. Effects of Antibiotic Prophylaxis in Patients with Open Fracture of the Extremities: A Systematic Review of Randomized Controlled Trials. JBJS Rev 2015;3:01874474-201503060-00002. doi:10.2106/JBJS. RVW.N.00088
25. Spencer FA, Lopes LC, Kennedy SA, Guyatt G. Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open 2014;4:e004282. doi:10.1136/bmjopen-2013-004282
26. Higgins JPT. GSe. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
27. Johnston SC, Easton JD, Farrant M, et al, Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 2018;379:215-25. doi:10.1056/NEJMoa1800410
28. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: Reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 2012;12:9. doi:10.1186/1471-2288-12-9
29. Guyatt GH, Ebrahim S, Alonso-Coello P. et al. GRADE guidelines 17: Assessing the risk of bias associated with missing participant outcome data in a body of evidence. J Clin Epidemiol 2017;87:14-22. doi:10.1016/j.jclinepi.2017.05.005
30. Guyatt GH, Oxman AD, Santesso N. et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 2013;66:158-72. doi:10.1016/j.jclinepi.2012.01.012
31. Wang D, Gui L, Dong Y. et al. Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: A subgroup analysis of the CHANCE trial. Stroke Vasc Neurol 2016;1:29-36. doi:10.1136/svn-2016-000008
32. Wang X, Zhao X, Johnston SC, et al, CHANCE investigators. Effect of clopidogrel with aspirin on functional outcome in TIA or minor stroke: CHANCE substudy. Neurology 2015;85:573-9. doi:10.1212/ WNL.0000000000001844
33. Wang YL, Pan YS, Zhao XQ, et al, CHANCE investigators. Recurrent stroke was associated with poor quality of life in patients with transient ischemic attack or minor stroke: Finding from the CHANCE trial. CNS Neurosci Ther 2014;20:1029-35. doi:10.1111/cns.12329
34. Huang Y, Li M, Li JY. et al. The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: A systematic review. PLoS One 2013;8:e65754. doi:10.1371/journal.pone.0065754
35. Liu Y, Fei Z, Wang W, Fang J, Zou M, Cheng G. Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: A meta-analysis of 10 randomized controlled trials. J Neurol 2016;263:2247-59. doi:10.1007/s00415-016-8260-7
36. Ding L, Peng B. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: A systematic review and meta-analysis. Eur J Neurol 2018;25:1276-84. doi:10.1111/ene.13695
37. Palacio S, Hart RG, Pearce LA. et al. Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials. Int J Stroke 2015;10:686-91. doi:10.1111/ijs.12050
38. Sacco RL, Diener HC, Yusuf S, et al, PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008;359:1238-51. doi:10.1056/NEJMoa0805002